StockData
Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. (MD) stock

MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/308% above fair value
$31.40−0.05 (-0.16%)

Close on Nov 12, 2026Market cap $2.45BP/E 17.1Yield –

Earnings

Pediatrix Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 18, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$501.40M
+1.7% on a year earlier
Adjusted EPS, Q3 FY2026
$0.72
$0.67 a year earlier
Latest guidance
Issued
Oct 29, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Pediatrix Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 18, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 29, 2026before the open$501.40M+1.7%$0.59$0.72Release
Q2 FY2026ended Jun 30, 2026Jul 15, 2026before the open––––Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open$476.20M+3.9%$0.36$0.44Release
Q4 FY2025ended Dec 31, 2025Feb 19, 2026before the open$493.80M–$0.40$0.50Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025before the open$492.90M-3.6%$0.84$0.67Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$468.80M-7.0%$0.46$0.53Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open$458.40M-7.4%$0.24$0.33Release
Q4 FY2024ended Dec 31, 2024Jan 13, 2025before the open––––Release
Q3 FY2024ended Sep 30, 2024Nov 1, 2024before the open$511.20M+0.9%$0.23$0.44Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$504.30M+0.7%-$1.84$0.34Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open$495.10M+0.8%$0.05$0.20Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Pediatrix Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Adjusted EBITDAnon-GAAPFY2026$290.00M – $300.00M–NewOct 29, 2026
Adjusted EBITDAnon-GAAPFY2026$280.00M – $300.00M$280.00M – $300.00MReaffirmedJul 15, 2026

Guidance history

Every forecast Pediatrix Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 29, 2026Adjusted EBITDAFY2026$290.00M – $300.00MNew
Jul 15, 2026Adjusted EBITDAFY2026$280.00M – $300.00MReaffirmed
May 5, 2026Adjusted EBITDAFY2026$280.00M – $300.00MReaffirmed
Feb 19, 2026Adjusted EBITDAFY2026$280.00M – $300.00MNew
Nov 3, 2025Adjusted EBITDAFY2025$270.00M – $290.00MNew
Aug 5, 2025Adjusted EBITDAFY2025$245.00M – $255.00MRaised
May 6, 2025Adjusted EBITDAFY2025$220.00M – $240.00MNew
Jan 13, 2025adjusted EBITDAFY2024$205.00M – $215.00MReaffirmed
Nov 1, 2024Adjusted EBITDAFY2024$205.00M – $215.00MNarrowed
Aug 6, 2024Adjusted EBITDAFY2024$200.00M – $220.00MReaffirmed
May 7, 2024Adjusted EBITDAFY2024$200.00M – $220.00MReaffirmed
Feb 20, 2024Adjusted EBITDAFY2024$200.00M – $220.00MNew
Nov 2, 2023Adjusted EBITDAFY2023$200.00M – $210.00MLowered
Aug 3, 2023Adjusted EBITDAFY2023$235.00M – $245.00MReaffirmed
May 2, 2023Adjusted EBITDAFY2023$235.00M – $245.00MReaffirmed
Feb 17, 2023Adjusted EBITDAFY2023$235.00M – $245.00MNew
Nov 3, 2022Adjusted EBITDAFY2022$240.00M – $245.00MLowered
Aug 4, 2022Adjusted EBITDAFY2022$260.00M – $270.00MLowered
Feb 17, 2022Adjusted EBITDAFY2022$270.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Pediatrix Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  2. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  3. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  4. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  5. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  6. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  7. Executive Vice President, Chief Financial Officer & Treasurer
    Update
  8. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  9. Executive Vice President, Chief Financial Officer and Treasurer
    Update
  10. Executive Vice President, Chief Financial Officer & Treasurer
    Results
  11. Senior Vice President, Finance and Strategy
    Results
  12. Pediatrix Announces Strategic Initiatives For
    Results
  13. Senior Vice President, Finance and Strategy
    Results
  14. Senior Vice President, Finance and Strategy
    Results
  15. Pediatrix Medical Group, Inc. (NYSE:MD) Supplemental Disclosure May 30, 2024
    Update

See a number that looks wrong?